Genetic variants in the complement system predisposing to age-related macular degeneration: A review
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is a major cause of visual impairment in the western world. It is characterized by the presence of lipoproteinaceous deposits (drusen) in the inner layers of the retina. Immunohistochemistry studies identified deposition of complement proteins in the drusen as well as in the choroid. In the last decade, genetic studies have linked both common and rare variants in proteins of the complement system to increased risk of development of AMD. Here, we review the variants described to date and discuss the functional implications of dysregulation of the alternative pathway of complement in AMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449 · cited 1×
“Subsequent genetic studies identified a common single nucleotide polymorphism (SNP) in the CFH gene (rs1061170) (Figure 2A) that is associated with increased risk of developing AMD (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
BackgroundComplement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424 · cited 1×
“Subsequent genetic studies identified a common single nucleotide polymorphism (SNP) in the CFH gene (rs1061170) (Figure 2A) that is associated with increased risk of developing AMD (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
BackgroundHageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961 · cited 1×
“Subsequent genetic studies identified a common single nucleotide polymorphism (SNP) in the CFH gene (rs1061170) (Figure 2A) that is associated with increased risk of developing AMD (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265 · cited 3×
“The implication that complement was somehow involved in AMD initiation and/or progression initially focused around the discovery of complement byproducts in drusen, including the main soluble regulator complement factor H (FH) (Hageman et al., 2001).”
BackgroundInfluentialDrusen proteome analysis: an approach to the etiology of age-related macular degeneration
Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222551899 · Cited by 1,208 · cited 1×
“Drusen are extracellular deposits containing cellular debris, lipids and various protein components including a number from the innate immune system (Johnson et al., 2000; Mullins et al., 2000; Crabb et al., 2002; Anderson et al., 2010).”
BackgroundThe AMD Genetics Clinical Study Group, Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1750 · Cited by 1,075 · cited 2×
“Both haplotypes are considered highly protective against developing AMD, although the current hypothesis is that the protection is mediated by the FB mutations (Gold et al., 2006; Maller et al., 2006).”
BackgroundMullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
Complement C3 variant and the risk of age-related macular degeneration
Yates, J. R. W., Sepp, T., Matharu, B. K., Khan, J. C., Thurlby, D. A., Shahid, H., Clayton, D. G., Hayward, C., Morgan, J., Wright, A. F., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072618 · Cited by 829 · cited 1×
“A common SNP (rs2230199) in C3 results in a R102G (pro-C3 numbering; R80G in the mature protein) substitution (Figure 2C) that is associated with risk of AMD (odds ratio 2.6) (Maller et al., 2007; Yates et al., 2007).”
BackgroundInfluentialSeven new loci associated with age-related macular degeneration
The AMD Gene Consortium (2013) · Nature Genetics · doi:10.1038/ng.2578 · Cited by 788
Cited by
Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences
Pastor, J. C., Rojas, J., Pastor-Idoate, S., Di Lauro, S., Gonzalez-Buendia, L., & Delgado-Tirado, S. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.07.005 · Cited by 344
Clinical promise of next-generation complement therapeutics
Mastellos, D. C., Ricklin, D., & Lambris, J. D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0031-6 · Cited by 343
The complement system in age-related macular degeneration
Armento, A., Ueffing, M., & Clark, S. J. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03796-9 · Cited by 258
Self-citationBoyer, D. S., Schmidt-Erfurth, U., van Lookeren Campagne, M., Henry, E. C., & Brittain, C. (2017) · Retina · doi:10.1097/iae.0000000000001392 · Cited by 258
Pharmaceutical development of AAV-based gene therapy products for the eye
Rodrigues, G. A., Shalaev, E., Karami, T. K., Cunningham, J., Slater, N. K. H., & Rivers, H. M. (2019) · Pharmaceutical Research · doi:10.1007/s11095-018-2554-7 · Cited by 213
“Many of the SNPs occur in genes encoding components of the complement pathway (27).”
BackgroundCharbel Issa, P., Barnard, A. R., Herrmann, P., Washington, I., & MacLaren, R. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506960112 · Cited by 124
Towards the application of precision medicine in Age-Related Macular Degeneration
Cascella, R., Strafella, C., Caputo, V., Errichiello, V., Zampatti, S., Milano, F., Potenza, S., Mauriello, S., Novelli, G., Ricci, F., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.11.004 · Cited by 76
Clark, S. J., McHarg, S., Tilakaratna, V., Brace, N., & Bishop, P. N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01778 · Cited by 71
“Most complement genes implicated in AMD are central components of the alternative pathway of complement activation, including CFH, CFI, CFB, and C3 (3).”
BackgroundSelf-citationRetinal pigment epithelial cells mitigate the effects of complement attack by endocytosis of C5b-9
Georgiannakis, A., Burgoyne, T., Lueck, K., Futter, C., Greenwood, J., & Moss, S. E. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500937 · Cited by 41
Ram, S., Shaughnessy, J., DeOliveira, R. B., Lewis, L. A., Gulati, S., & Rice, P. A. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.05.016 · Cited by 35
Therapeutic targeting of the complement system in ocular disease
Rathi, S., Hasan, R., Ueffing, M., & Clark, S. J. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103757 · Cited by 24
Self-citationLoeven, M. A., van Gemst, J. J., Schophuizen, C. M. S., Tilakaratna, V., van den Heuvel, L. P., Day, A. J., Klevering, B. J., & van der Vlag, J. (2018) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.iovs-17-22893 · Cited by 17
Metadata
- Authors
- Schramm, E. C., Clark, S. J., Triebwasser, M. P., Raychaudhuri, S., Seddon, J. M., & Atkinson, J. P.
- Venue
- Molecular Immunology
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 61
- Issue
- 2
- Pages
- 118-125
- ISSN
- 0161-5890 (ISSN-L)
- OpenAlex
- W1987637624
- Cited by
- 121
- References
- 20
- FWCI
- 13.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.